Surabhi Mandal

Surabhi Mandal

Auto-generated profile, based on publicly available information

Surabhi Mandal

Himalayan Pharmacy Institute, Majitar, Rongpo, Sikkim, India

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 October 2025 in Pharmaceutical Nanotechnology
Verified
Journal Article
Closed access
PDF file
DADr. Faruk Alam
Dr. Faruk Alam
PSPrasurjya Saikia
Prasurjya Saikia
DKDurgaprasad Kemisetti
Durgaprasad Kemisetti
SMSurabhi Mandal
Surabhi Mandal
ARAmrit Kumar Rath
Amrit Kumar Rath
SSSanket Seksaria
Sanket Seksaria
Carbon nanotubes (CNTs) have emerged as extremely promising nanocarriers for drug delivery due to their superior structural, mechanical, and electrical capabilities. This study digs into recent advances in CNT-based drug delivery systems, focusing on novel functionalization strategies, hybrid nanostructures, and customized nanocarrier designs. Functionalization using polymers, peptides, and other bioactive compounds has dramatically improved CNT solubility, biocompatibility, and precise targeting. Furthermore, hybrid nanostructures that combine CNTs with nanoparticles, liposomes, or metallic components have higher drug-loading capacities, multifunctional therapeutic effectiveness, and controlled drug-release features. CNTs may be customized in size, shape, and surface chemistry, allowing for the development of precise delivery systems that are particularly useful in cancer and complicated disease therapy. However, despite these advances, cytotoxicity, regulatory limits, and difficulty with large-scale manufacturing impede clinical translation. Sustainable methods, thorough safety assessments, and advanced technology like artificial intelligence to maximize functionality and design are all necessary to overcome these obstacles. Future research should focus on overcoming these hurdles to fully realize CNTs' potential as flexible, effective, and safe nanocarriers in drug delivery applications.

27 October 2025 in Asian Journal of Chemistry
Verified
Journal Article
Open access
PDF file
DADr. Faruk Alam
Dr. Faruk Alam
MNMrinmoy Nag
Mrinmoy Nag
MJMoidul Islam Judder
Moidul Islam Judder
SMSurabhi Mandal
Surabhi Mandal
BSBhupendra Shrestha
Bhupendra Shrestha
MIMohidul Islam
Mohidul Islam
The field of nanotechnology continues to offer profound implications across biomedical, environmental and materials science domains with metallic nanoparticles (MNPs) at the forefront due to their size-dependent physical and chemical attributes. This review provides a critical evaluation of the biosynthesis of MNPs particularly gold (AuNPs) and silver nanoparticles (AgNPs) employing plant-derived phytochemicals and microbial metabolites as reducing and stabilizing agents. The biosynthetic route is compared against conventional top-down and bottom-up methods, with specific attention to the influence of synthesis parameters (e.g. pH, temperature, extract concentration) on nanoparticle morphology, yield and surface chemistry. The unique optical and surface plasmon resonance properties of noble metals are discussed in the context of their biomedical applications, notably in antimicrobial coatings, cancer therapeutics, drug delivery vectors and diagnostic platforms. Moreover, functional nanoparticles of other metals (Pd, Cu, Fe, Fe3O4, α-Fe2O4, and nZVI) are examined for their roles in catalysis, pollutant degradation and water treatment. The review also delineates analytical techniques employed in nanoparticle characterization, encompassing structural, compositional, and surface profiling. Finally, the clinical relevance and translational potential of green-synthesized MNPs are contextualized within the broader framework of sustainable nanomaterials development.

12 November 2025 in Current Indian Science
Verified
Journal Article
Closed access
SRShivam Rongpi
Shivam Rongpi
PSPrasurjya Saikia
Prasurjya Saikia
CTCharlisar Teron
Charlisar Teron
ABAbhranil Bhuyan
Abhranil Bhuyan
SDSunmon Raj Dutta
Sunmon Raj Dutta
DKDurgaprasad Kemisetti
Durgaprasad Kemisetti
Northeastern India, recognized as a significant biodiversity hotspot, has a long-standing ethnomedicine tradition. The present study investigated the plant species employed by indigenous populations within the region for wound healing. Through comprehensive field surveys in conjunction with literature reviews, we identified 20 distinct plant species across 15 families utilized by different tribes for wound treatment. This includes communities such as the Garos from Garo Hills, the Nyishi and Wancho from Arunachal Pradesh, and the Kuki and Ahom and Karbi from Karbi Anglong. Conventional healing practitioners use different parts of these botanical samples, such as leaves, roots, and stems, in various formulations, such as pastes, extracts, and decoctions. This study investigated the different preparation methods and application techniques associated with each plant species. We also evaluated the bioactive compounds in these plants, including flavonoids, tannins, and asiaticoside, that contribute to their woundhealing properties. This research further stresses the possibility of combining traditional knowledge with modern medical practices to innovate wound-healing therapies. We discuss the use of botanical gels, such as Cresilon Traumagel, which harness the biological activities of Centella asiatica for therapeutic purposes. Such an approach is thus promising for developing safe, accessible, and productive solutions in wound care. This paper contributes to preserving traditional knowledge by documenting and analysing these ethnomedical practices, which can provide valuable insights for developing innovative wound-healing strategies. These findings highlight the need for exploration of the rich flora of Northeast India for potential therapeutic agents and the integration of traditional wisdom with modern technology for better wound care.

21 January 2026 in Pharmaceutical Nanotechnology
Verified
Journal Article
Closed access
PSPrasurjya Saikia
Prasurjya Saikia
RDRajeswar Das
Rajeswar Das
GCGowri Sankar Chintapalli
Gowri Sankar Chintapalli
STSadique Hussain Tapadar
Sadique Hussain Tapadar
RBRajnandan Borah
Rajnandan Borah
DKDurgaprasad Kemisetti
Durgaprasad Kemisetti
The potential of micro- and nanorobots in biomedical applications has drawn significant interest. These devices are modeled after natural organisms such as bacteria and sperm cells. By utilizing the propulsion mechanisms of motile sperm and other microorganisms, these biohybrid systems offer innovative approaches for drug delivery, assisted reproduction, and disease therapy in fluidic environments. Despite advancements, replicating the intricate architecture and functions of natural sperm cells at the nanoscale remains challenging, particularly regarding size homogeneity, flexibility, and propulsion efficiency. Recent efforts have focused on developing artificial sperm-like nanorobots with enhanced motility using techniques such as electrospinning, 3D printing, and magnetic assembly. These spermbots demonstrate the ability to transport targeted payloads, navigate through biofluids, and potentially address male infertility. Furthermore, integrating external control systems— such as magnetic fields and chemical stimuli—enables precise regulation of spermbot movement and function. Although clinical translation is still in its early stages, preclinical studies have highlighted the promise of spermbots in targeted drug delivery, tumor therapy, and reproductive medicine. However, challenges related to biocompatibility, biodegradability, and ethical considerations— particularly regarding their application in human reproduction—must be addressed before these systems can be widely adopted in therapeutic settings.